3D Telemedicine During COVID-19: Cohort Study

NCT04444323 | Completed

• 1 other identifier: GN20HS300
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

It is critical to establish an effective form of telemedicine during the Covid 19 pandemic, that will allow safe social distancing of clinicians and patients. Canniesburn Regional Plastic Surgery and Burns Unit serves as the regional plastic, burns and reconstructive centre for West of Scotland, population 3 million. All face to face clinics have been cancelled and converted to telephone/telemedicine only consultations. The research will establish both 2D and 3D telemedicine as normal patient follow up practice during this period.The project therefore aims to implement a 3D telemedicine system to facilitate patient follow up and remote physiotherapy, that will act as if the patient is physically 'present' in the room. Physiotherapy is crucial to patient outcomes after burns contractures, hand trauma and cancer reconstruction. The 3D telemedicine system will be built by an industrial partner, with CE marked equipment, specifically to help during the Covid-19 Pandemic.

Conditions

Telemedicine; Surgery, Plastic

Keywords

3-D

Outcome Measures

Primary Outcomes (1)

• Presence Questionnaire

  Version 3 of PQ, 29 item rating scale of "presence". Witmer 2005

  Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]

Secondary Outcomes (6)

• University Hospital of North Northway Questionnaire

  Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]

• Telehealth Usability Questionnaire

  Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]

• System Usability Scale

  Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]

• Mental Effort Rating Scale

  Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]

• NASA TLX

  Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]

Other Outcomes (2)

• Reliability

  Single time point at day 1 (whether telemedicine is successful)

• Image distortion

  Single time point at day 1 (whether telemedicine has distortion)

Study Arms (1)

3D Telemedicine

EXPERIMENTAL

Single arm. All patient seen face-to-face and then with 3D telemedicine.

Other: 3D Telemedicine

Interventions

3D Telemedicine OTHER

The intervention is a consultation conducted using a 3D form of telemedicine

3D Telemedicine

Eligibility Criteria

• Age: 1 Year - 95 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with breast cancer reconstruction
• Patients with sarcoma
• Patients with head \& neck reconstruction
• Patients with flap reconstruction
• Patients with limb reconstruction
• Patients with hand trauma
• Patients with burns
• Patients with cleft lip
• Patients able to read and understand English
• Patients able to give informed consent

You may not qualify if:

• Patients who do not have capacity to consent
• Patients who are registered blind or deaf

Sponsors & Collaborators

• NHS Greater Glasgow and Clyde: lead
• Jean Brown Bequest Fund, Glasgow: collaborator

Study Sites (1)

Canniesburn Regional Plastic Surgery and Burns Unit

Glasgow, Scotland, G4 0SF, United Kingdom

Location

Related Publications (1)

• Lo S, Fowers S, Darko K, Spina T, Graham C, Britto A, Rose A, Tittsworth D, McIntyre A, O'Dowd C, Maguire R, Chang W, Young D, Hoak A, Young R, Dunlop M, Ankrah L, Messow M, Ampomah O, Cutler B; 3DTM (3D Telemedicine) Collaborative research group; Armstrong R, Lalwani R, Davison R, Bagnall S, Hudson W, Shepperd M, Johnson J. Participatory development of a 3D telemedicine system during COVID: The future of remote consultations. J Plast Reconstr Aesthet Surg. 2023 Dec;87:479-490. doi: 10.1016/j.bjps.2022.10.012. Epub 2022 Oct 13.

  PMID: 36890078 DERIVED

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Masking Details: Data analysis will be masked
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Single cohort patients seen face-to-face and then by 3D telemedicine

Study Record Dates

• First Submitted: June 20, 2020
• First Posted: June 23, 2020
• Study Start: July 10, 2021
• Primary Completion: March 31, 2022
• Study Completion: March 31, 2022
• Last Updated: May 26, 2022

Record last verified: 2022-05

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)